(Press-News.org) DURHAM, N.C. – Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients with heart attacks.
For certain heart patients older than age 75, a half-dose of the anti-platelet drug prasugrel works about as well as the typical dosage of clopidogrel, according to a team led by the Duke Clinical Research Institute that looked at a sub-study of a large clinical trial.
"As people live longer throughout the world, it's increasingly important to establish appropriate treatments for conditions such as acute coronary syndromes that commonly occur later in life," said Matthew T. Roe, M.D., MHS, associate professor of medicine at Duke and lead author of a study published Aug. 20, 2013, in the journal Circulation.
"These patients are very vulnerable to side effects, including bleeding, if therapies are not properly dosed," Roe said. "Additionally, existing practice guidelines have few specific recommendations for older patients with acute coronary syndromes as little evidence has been accrued from prior clinical trials in this population."
People older than age 75 comprise less than 10 percent of the U.S. population, but account for 35 percent of patients with acute coronary syndrome (ACS), which includes a recent heart attack or unstable chest pain. ACS is typically treated with anti-platelet therapies.
Earlier studies, for example, had shown that the platelet inhibitor prasugrel reduced the risk of adverse outcomes compared with clopidogrel in ACS patients undergoing coronary stent implantation. Those studies used a 60-mg initial dose followed by a 10-mg/day maintenance dose.
At that dosage level, however, patients older than age 75 had an increased risk of intracranial and fatal bleeding, as did younger patients weighing 132 pounds or less. The results led to warnings by the U.S. Food and Drug Administration and the European Medicines Agency for the use of the 10 mg/day maintenance dose of prasugrel in those populations, and consideration of a reduced dose (5 mg/day) to mitigate bleeding complications.
To examine whether older patients might benefit from a lower dosage of prasugrel, the Duke-led researchers analyzed more than 2,000 older patients who participated in a large trial called TRILOGY ACS that compared prasugrel with clopidogrel to manage acute coronary syndromes without coronary stent implantation or coronary bypass surgery.
The findings from this study, the first long-term data on outcomes specifically from elderly patients treated with the reduced dose of prasugrel, determined that a smaller dosage of 5-mg/day of prasugrel presented no greater risk of bleeding problems than the commonly prescribed 75-mg dose of clopidogrel in the elderly population.
"The findings from our study indicate how difficult it is to identify the right dose of anti-clotting medications for the elderly, to improve outcomes after a heart attack," said co-author Magnus Ohman, professor of medicine at Duke and chairman of the TRILOGY ACS study. "While a lower dose seemed intuitive, it was safe but not more effective. Future dedicated studies need to continue to find the right therapies for the vulnerable elderly patients."
###
In addition to Roe and Ohman, study authors include Shaun Goodman; Susanna Stevens; Judith Hochman; Shmuel Gottlieb; Bikur Cholim; Felipe Martinez; Anthony Dalby; William Boden; Harvey White; Dorairaj Prabhakaran; Kenneth Winters; Philip Aylward; Jean-Pierre Bassand; Darren McGuire; Diego Ardissino; Keith A.A. Fox; and Paul Armstrong.
The drug companies Eli Lilly and Daiichi Sankyo, which market and make prasugrel, funded the TRILOGY ACS study.
Roe receives grant funding and/or consulting fees from Lilly and Daiichi Sankyo. Ohman receives grant funding and travel expenses from the Lilly and Daiichi Sankyo. More detailed disclosures are provided in the published study.
Drug dosing for older heart patients should differ
2013-08-16
ELSE PRESS RELEASES FROM THIS DATE:
JPIDS explores trends in perinatally infected HIV patients now approaching adulthood
2013-08-16
ARLINGTON, VA, August 16, 2013—The advent of antiretroviral therapy (ART) has transformed HIV from a death sentence into a chronic disease. In one of the largest studies of perinatally infected HIV (PHIV) patients to date, Agwu, et al, found that the proportion of patients on ART has increased and rates of viremia and advanced immunosuppression have decreased. But the rates of both markers in older patients are higher, according to an article in the Fall issue of The Journal of the Pediatric Infectious Diseases Society (JPIDS).
The retrospective study of the HIV Research ...
Autistic kids who best peers at math show different brain organization, Stanford/Packard study shows
2013-08-16
STANFORD, Calif. — Children with autism and average IQs consistently demonstrated superior math skills compared with nonautistic children in the same IQ range, according to a study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
"There appears to be a unique pattern of brain organization that underlies superior problem-solving abilities in children with autism," said Vinod Menon, PhD, professor of psychiatry and behavioral sciences and a member of the Child Health Research Institute at Packard Children's.
The autistic ...
Female frogs prefer males who can multitask
2013-08-16
From frogs to humans, selecting a mate is complicated. Females of many species judge suitors based on many indicators of health or parenting potential. But it can be difficult for males to produce multiple signals that demonstrate these qualities simultaneously.
In a study of gray tree frogs, a team of University of Minnesota researchers discovered that females prefer males whose calls reflect the ability to multitask effectively. In this species (Hyla chrysoscelis) males produce "trilled" mating calls that consist of a string of pulses.
Typical calls can range in ...
Nanosensors could aid drug manufacturing
2013-08-16
CAMBRIDGE, MA - MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs — especially those based on antibodies — more safely and efficiently.
Using these sensors, the researchers were able to characterize variations in the binding strength of antibody drugs, which hold promise for treating cancer and other diseases. They also used the sensors to monitor the structure of antibody molecules, including whether they contain a chain of sugars that interferes with proper ...
How DNA repair helps prevent cancer
2013-08-16
The biological information that makes us unique is encoded in our DNA. DNA damage is a natural biological occurrence that happens every time cells divide and multiply. External factors such as overexposure to sunlight can also damage DNA.
Understanding how the human body recognizes damaged DNA and initiates repair fascinates Michael Feig, professor of biochemistry and molecular biology at Michigan State University. Feig studies the proteins MutS and MSH2-MSH6, which recognize defective DNA and initiate DNA repair. Natural DNA repair occurs when proteins like MutS (the ...
NASA sees Tropical Storm Pewa develop in central Pacific
2013-08-16
NASA's Aqua satellite passed over two developing low pressure areas in the Central Pacific Ocean, just before one of them strengthened into Tropical Storm Pewa.
When NASA's Aqua satellite passed over the Central Pacific on Aug. 16 at 00:35 UTC (8:35 p.m. EDT/Aug. 15), the Moderate Resolution Imaging Spectroradiometer or MODIS instrument captured a visible image of two developing low pressure areas. The low farthest west was called System 91C, and that's the low that strengthened into Tropical Storm Pewa. The low pressure area east of Pewa is System 90C, which has a high ...
Erin weakens to a tropical depression over eastern Atlantic
2013-08-16
Tropical Storm Erin ran into cooler waters and dry, stable air over the Eastern Atlantic that sapped its strength and weakening the storm to depression status. NOAA's GOES-East satellite showed the storm waning today.
NOAA's GOES-East satellite captured a visible image of Tropical Depression Erin on Aug. 16 at 1445 UTC/10:45 a.m. EDT. The image was created by NASA's GOES Project at NASA Goddard Space Flight Center in Greenbelt, Md. and showed that the storm still had good circulation, but the clouds and showers had diminished. The National Hurricane Center noted that ...
Good-looking birds: Sexual attractiveness in the wild turkey
2013-08-16
Why are some individuals more attractive to the opposite sex than others? New research by a team from University College London and Oxford University, published in PLOS Genetics, has shown that in wild turkeys (Meleagris gallopavo), the essence of male beauty is mainly dependent on the way that males use their genes, rather than differences in the genes themselves.
Males and females in many animals show profound differences in how they look and act, and some of these differences are key to sexual attractiveness. Within each sex, individuals often show a range of these ...
Consuming a high-quality diet is associated with lower risk of pancreatic cancer
2013-08-16
People who reported dietary intake that was most consistent with the 2005 Dietary Guidelines for Americans had lower risk of pancreatic cancer, according to a new study published August 15 in the Journal of the National Cancer Institute.
Previous studies investigating the relationship between food and nutrient intake and pancreatic cancer have yielded inconsistent results. The U.S. Government issues evidence-based dietary guidelines that provide the basis for federal nutrition policy and education activities to promote overall health for Americans. The authors evaluated ...
Unearthed: Fossil of history's most successful mammal
2013-08-16
This release is also available in Chinese on EurekAlert! Chinese.
The 160 million-year-old fossil of an extinct rodent-like creature from China is helping to explain how multituberculates—the most evolutionarily successful and long-lived mammalian lineage in the fossil record—achieved their dominance.
This fossil find—the oldest ancestor in the multituberculate family tree—represents a newly discovered species known as Rugosodon eurasiaticus. The nearly complete skeleton provides critical insights into the traits that helped such multituberculates thrive in their day. ...